Rana Usman, MD
Hematology & Oncology · Tupelo, MSNPI 1356829097
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 90.8% of the total across 126 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 43 manufacturers, the largest accounting for just 13.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,758, more than ten times the $76 reported in 2021. That places this record below the midpoint for hematology & oncology clinicians in MS, where the typical reported total is $9,632.
Across 126 payments — averaging $22.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$361
- GSK$233
- Bristol Myers Squibb$214
- Merck$175
- Gilead$148
- Lilly USA, LLC$127
- plus $2K from 37 others
What the payments were for
- Food & beverage$2,52691%
- Education$2559%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 12 | $361 |
| GSK | 13 | $233 |
| Bristol Myers Squibb | 9 | $214 |
| Merck | 8 | $175 |
| Gilead(2 entities) | 6 | $148 |
| Lilly USA, LLC | 3 | $127 |
| Pfizer | 7 | $117 |
| Sobi, Inc | 1 | $100 |
| Genentech USA, Inc. | 3 | $99 |
| Daiichi Sankyo Inc. | 4 | $87 |
| AstraZeneca | 4 | $79 |
| Johnson & Johnson | 5 | $77 |
| Bayer | 4 | $71 |
| Abbott | 1 | $69 |
| AbbVie | 4 | $63 |
| Sanofi | 3 | $57 |
| Incyte Corporation | 3 | $55 |
| Astellas Pharma US Inc | 3 | $55 |
| Legend Biotech USA Inc. | 3 | $52 |
| Array Biopharma Inc | 3 | $51 |
| Stemline Therapeutics Inc. | 2 | $43 |
| Novartis | 2 | $39 |
| Exelixis Inc. | 2 | $31 |
| Tempus AI, Inc | 1 | $29 |
| Fennec Pharmaceuticals, Inc. | 2 | $29 |
| Boston Scientific | 1 | $27 |
| EMD Serono, Inc. | 1 | $24 |
| Tersera Therapeutics LLC | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| ADC Therapeutics America, Inc. | 1 | $20 |
| Immunocore Limited | 1 | $20 |
| Boehringer Ingelheim | 1 | $19 |
| Jazz Pharmaceuticals Inc. | 1 | $18 |
| Novo Nordisk | 1 | $17 |
| Genmab U.S., Inc. | 1 | $16 |
| Recordati_rare_diseases_inc. | 1 | $16 |
| Sanofi Pasteur Inc. | 1 | $15 |
| Taiho Oncology, Inc. | 1 | $14 |
| Agios Pharmaceuticals, Inc. | 1 | $14 |
| Beigene USA, Inc. | 1 | $14 |
| Kyowa Kirin, Inc. | 1 | $14 |
| Deciphera Pharmaceuticals Inc. | 1 | $13 |
| Sirtex Medical Inc | 1 | $12 |
How this compares
$2,781 in reported general payments places this provider in the 20th percentile of 57 hematology & oncology providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 29 | $1,117 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 16 | $379 |
| Ondansetron Hcl | 23 | $103 |
| Potassium Chloride | 14 | $56 |
Paid to pharmacies, not to this prescriber.
Other hematology & oncology in Tupelo
- Paschal WilsonTupelo$7K
- Charles MontgomeryTupelo$6K
- Julian HillTupelo$3K
- Amit JainTupelo$3K
- Andrew KellumTupelo$2K
- Solly ChedidPascagoula$1.7M
- Carter MilnerJackson$248K
- Guangzhi QuJackson$59K
- Jennifer EubanksMeridian$44K
- Daniel PattersonPascagoula$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.